Doctor profile · Federal record

Dr. Athanasios Papakostas, MD

Retina Specialist (Ophthalmology) Physician (CMS: Ophthalmology) · Ophthalmology Physician · Ophthalmology Physician · Retina Specialist (Ophthalmology) Physician · Brentwood, MO

  • NPI 1588975346
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 19 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1600 S Brentwood Blvd Ste 700
Brentwood, MO 631441304
(314) 367-1181
Mailing address
8820 Ladue RD Ste 203
Saint Louis, MO 631242080

Credentials & registration

NPPES · NUCC
NPI registered
June 2010 — 16 yrs on file
Profile last updated
September 3, 2024
Year of graduation
2007 — 19 yrs since
Specialty taxonomy
207WX0107X — NUCC code
State licenses (2)
Missouri #2021010996 · New York #288286

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1588975346. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
38,046
Distinct HCPCS
10
Medicare allowed
$2,874,365
HCPCS Description Services Patients Avg allowed
J2777 Injection, faricimab-svoa, 0.1 mg 28,740 157 $36
92134 Imaging of retina 2,736 1,206 $38
J2778 Injection, ranibizumab, 0.1 mg 2,341 128 $232
67028 Injection of drug into eye 1,291 368 $115
92014 Established patient complete exam of visual system 1,020 696 $122
J0178 Injection, aflibercept, 1 mg 792 126 $860
99214 Established patient office or other outpatient visit, 30-39 minutes 512 391 $125
99204 New patient office or other outpatient visit, 45-59 minutes 180 180 $163
92004 New patient complete exam of visual system 136 136 $144
Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg 110 12 $229

In context: peer comparison

Among 8 peers in this city , average services per provider: 1,226. This provider delivers 31× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$11,295
Transactions
43
Manufacturers
10
Payer (manufacturer) Industry Txns Amount
Genentech USA, Inc. 14 $7,043.22
EyePoint Pharmaceuticals US, Inc. 3 $1,864.18
Alimera Sciences, Inc. 8 $1,628.50
Regeneron Healthcare Solutions, Inc. 4 $183.04
Amgen Inc. 2 $141.37
Bausch & Lomb Americas Inc. 1 $117.61
ABBVIE INC. 6 $114.61
Alcon Vision LLC 1 $93.77
Astellas Pharma US Inc 3 $85.55
Harrow Eye, LLC 1 $23.07

By nature of payment

Consulting Fee
$7,940
Food and Beverage
$1,643
Honoraria
$1,390
Travel and Lodging
$322

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
805
Patients
467
Total drug cost
$26,731
Drug Type Claims Patients Total cost
Prednisolone Acetate Generic 234 156 $8,207
Atropine Sulfate Generic 103 94 $4,162
Ketorolac Tromethamine Generic 98 36 $3,151
Moxifloxacin (Moxifloxacin Hcl) Brand 77 66 $2,562
Timolol Maleate Generic 58 23 $571
Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) Brand 48 27 $812
Ofloxacin Generic 45 41 $575
Brimonidine Tartrate Generic 43 13 $1,403
Latanoprost Generic 37 0 $525
Difluprednate Generic 16 0 $2,165

Frequently asked questions

Auto-generated from federal data
What is Dr. Athanasios Papakostas's medical specialty?
Dr. Athanasios Papakostas practices Retina Specialist (Ophthalmology) Physician in Brentwood, MO.
Where does Dr. Athanasios Papakostas practice?
Dr. Athanasios Papakostas practices at 1600 S Brentwood Blvd Ste 700, Brentwood, MO 631441304. Office phone: 3143671181.
What is Dr. Athanasios Papakostas's NPI?
Dr. Athanasios Papakostas's National Provider Identifier (NPI) is 1588975346, issued by NPPES.
Does Dr. Athanasios Papakostas accept Medicare assignment?
Yes. Dr. Athanasios Papakostas accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Athanasios Papakostas commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection, ranibizumab, 0.1 mg (HCPCS J2778). Source: CMS Medicare Physician & Other Practitioners file.